This federal contract award, valued at $6,312.96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product, under a Firm Fixed Price delivery order contract. The contract has an ultimate completion date of December 23, 2024.
This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical division. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.
The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime contractor, may utilize subcontractors to fulfill the contract requirements, but their identities are not provided in the information given.
Generated 3/21/25, 9:54 AM